Impact of Psoralen/UVA-Treatment on Survival, Activation, and Immunostimulatory Capacity of Monocyte-Derived Dendritic Cells
Authors:
- Scott R. MarshallSMScott R. Marshall
- Xiao-Nong WangXWXiao-Nong Wang
- Catharien M.U. HilkensCHCatharien M.U. Hilkens
- Anne M. DickinsonADAnne M. Dickinson
- 15 March 2008
- journal article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 85 (5) , 757-766
Abstract
Extracorporeal Photopheresis (ECP) has been shown to be an effective treatment of graft-versus-host disease, solid organ graft rejection, and other T-cell-mediated diseases. The mechanisms of action of ECP include lymphocyte apoptosis, cytokine modulation, and the induction of regulatory T cells. It has been suggested that dendritic cells (DCs) are more resistant to ECP-induced apoptosis and might be directly modulated by ECP. We tested this hypothesis using in vitro Psoralen/UVA (PUVA) treatment as an in vitro model of ECP. Monocyte-derived DCs (mo-DCs) were treated with 8-methoxypsoralen /UVA and analyzed for surface molecule expression, apoptosis markers, endocytosis, and migratory and immunostimulatory capacity. Mo-DC phenotype and cytokine secretion was tested after CD40L stimulation. Naive T cells stimulated with PUVA-treated mo-DCs were tested for Th1/Th2 cytokine secretion and associated chemokine receptor patterns. DCs underwent apoptosis after in vitro PUVA and in vivo ECP. In vitro, the induction of apoptosis was preceded by partial maturation of immature mo-DCs. PUVA-treated immature mo-DCs also exhibited enhanced migratory and immunostimulatory capacity. However, mo-DCs stimulation through CD40 ligation was abrogated and interleukin (IL)-12 secretion was abolished 24 hr after PUVA treatment. PUVA-treated mo-DCs skewed naive T cells toward a Th2 response as defined by increased IL-4, IL-10, and IL-13 and decreased interferon-gamma levels, and the expression of the Th2-associated chemokine receptors CCR4 and CCR10. The observed Th2 shift was partially reversed by exogenous IL-12. These data suggest that direct modulation of DC function as well as apoptosis contribute to the immunoregulatory effects of ECP.Keywords
This publication has 65 references indexed in Scilit:
- Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factorsBone Marrow Transplantation, 2005
- Extracorporeal photochemotherapy for paediatric patients with graft‐versus‐host disease after haematopoietic stem cell transplantationBritish Journal of Haematology, 2003
- Extracorporeal photochemotherapy in patients with steroid‐dependent Crohn’s disease: a prospective pilot studyAlimentary Pharmacology & Therapeutics, 2001
- Successful Use of Extracorporeal Photochemotherapy in the Treatment of Severe Acute and Chronic Graft-Versus-Host DiseaseBlood, 1998
- Extracorporeal photochemotherapy for treatment of drug-resistant graft-vs.-host diseaseTransplantation and Cellular Therapy, 1998
- REDUCTION OF THE INCIDENCE OF REJECTION BY ADJUNCT IMMUNOSUPPRESSION WITH PHOTOCHEMOTHERAPY AFTER HEART TRANSPLANTATIONTransplantation, 1994
- SUCCESSFUL TREATMENT OF HEART TRANSPLANT REJECTION WITH PHOTOPHERESISTransplantation, 1992
- Treatment of Systemic Sclerosis With Extracorporeal PhotochemotherapyArchives of Dermatology, 1992
- Extracorporeal photochemotherapy for the treatment of systemic lupus erythematosus. A Pilot studyArthritis & Rheumatism, 1992
- Treatment of Cutaneous T-Cell Lymphoma by Extracorporeal PhotochemotherapyNew England Journal of Medicine, 1987